Vitamin D supplementation in adolescents with irritable bowel syndrome: Is it useful?
Not Applicable
Completed
- Conditions
- Digestive SystemPaediatricsirritable bowel syndrome
- Registration Number
- PACTR201706002337124
- Lead Sponsor
- tanta university, faculty of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
adolescent diagnosed with IBS and vitamin D deficiency depending on ROME III criteria for diagnosis of childhood irritable bowel syndrome
Exclusion Criteria
children with recent use of antibiotics (4 weeks),
normal vitamin D level,
recent change in IBS therapy,
history of gut surgery or radiation,
celiac disease,
chronic drug therapy,
children with body mass index (BMI) of less than 18 or more than 25,
chronic disease such as renal failure or diabetes mellitus,
patients taking vitamin D supplementation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link vitamin D deficiency to irritable bowel syndrome pathogenesis in adolescents?
How does vitamin D supplementation compare to standard-of-care treatments for adolescent IBS in clinical trials?
Are there specific biomarkers that predict response to vitamin D therapy in pediatric IBS patients?
What adverse events are associated with high-dose vitamin D supplementation in adolescents with gastrointestinal disorders?
What combination therapies involving vitamin D show promise in managing refractory adolescent IBS cases?